Categories: HealthcareNews

Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022

Live Conference Call and Webcast at 4:30 p.m. ET

PRINCETON, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report third quarter 2022 financial results after the market close on Monday, November 7, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update.

Event Agile Therapeutics Third Quarter 2022 Financial Results Conference Call
Date Monday, November 7, 2022
Time 4:30 p.m. ET / 1:30 p.m. PT

A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.

About Agile Therapeutics, Inc.
Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website, Twitter account (@agilether), and LinkedIn account. 

CONTACT: Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com

Staff

Recent Posts

Medidata Wins Inaugural SCOPE Site Innovation Award for Pioneering Advancements in Site Experience with Leading-Edge Technology

Medidata Rave Companion, the industry’s first data entry companion, is recognized for improving the speed…

2 hours ago

TruBridge Announces Adoption of Limited Duration Stockholder Rights Plan

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) (the “Company”), a healthcare solutions company, announced today that…

2 hours ago

COPE Health Solutions Welcomes International Health Technology Expert Onto Its Board of Directors

Leading technology-enabled solutions firm helps health care providers and payers improve quality and financial performance…

2 hours ago

Unite Us Enables CBO Reimbursement Under Oregon’s 1115 Medicaid Waiver

Connect Oregon streamlines Medicaid billing for community-based organizations (CBOs) using Unite Us Payments, increasing access…

2 hours ago

Leading Pioneer in Treatment of TMJ/TMD to Partner with In Hand Dental for Patient Monitoring

Dr. Anthony P. Urbanek, D.D.S., M.S., M.D., one of the country's most highly regarded Oral…

2 hours ago

SphingoTec Announces Management Changes

BERLIN, GERMANY / ACCESSWIRE / March 26, 2024 / Diagnostic company SphingoTec announces a significant…

2 hours ago